General Clinical Chemistry Analyzers and Accessories
YMC America, Inc TriBioC4 Acc 300A 1.9um 5x.3mm
YMC-Triart phases are based on organic/inorganic hybrid particles that combine the high mechanical stability and efficiency of a silica-based packing material with the robust chemical stability of a polymer-based packing material This versatile resin is produced using tightly controlled particle formation technology adapted from micro-reactor technology The resulting uniform particle and pore size distributions as well as the smooth surface greatly contribute to excellent peak shape and separation reproducibility In addition YMC-Triart materials are highly resilient and robust when used at extreme pH elevated temperature and high pressure
YMC America, Inc Tri BioC18 300A 3um 10x2.1mm
YMC-Triart phases are based on organic/inorganic hybrid particles that combine the high mechanical stability and efficiency of a silica-based packing material with the robust chemical stability of a polymer-based packing material This versatile resin is produced using tightly controlled particle formation technology adapted from micro-reactor technology The resulting uniform particle and pore size distributions as well as the smooth surface greatly contribute to excellent peak shape and separation reproducibility In addition YMC-Triart materials are highly resilient and robust when used at extreme pH elevated temperature and high pressure
Bio Rad Laboratories TRANS-BLOT TURBO TRANSFER PACK
10 mini nitrocellulose transfer pack for Trans-Blot Turbo Rapid Transfer Instrument. (170-4158)
ELITechGroup Drive hub, universal, 12/30 place, Aero/Cyto
Drive hub, universal, 12/30 place, Aero/Cyto
AdipoGen Yohimbine hydrochloride
Chemical. CAS 65-19-0. Formula C21H26N2O3 . HCl. MW 354.4 . 36.5. Synthetic. alpha2-Adrenoceptor antagonist. pKi values are 8.52, 8.00 and 9.17 for human alpha2A, alpha2B and alpha2C receptors, respectively.
Abcam TC 14012, Peptidomimetic C x CR4 antagonist, 5MG
MW 2066.4 Da, Purity >95%. TC 14012, Peptidomimetic CXCR4 antagonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam LRRK2-IN-1, LRRK2 inhibitor, 100MG
MW 570.7 Da. Potent and selective inhibitor of the Parkinson's disease kinase LRRK2. Benzodiazepine based derivative. Inhibits both G2019S mutant and wild-type LRRK2 kinase activity (IC₅₀ values are 6 and 13 nM respectively). Causes dephosphorylation, ubiquitination and degradation of LRRK2. Inhibits IFN-γ-induced monocyte maturation in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Ispinesib (SB-715992), 100MG
MW 517.1 Da, Purity >98%. A potent, selective and reversible allosteric inhibitor of KSP with IC₅₀ value of 0.5 nM. Often combines with chemotherapy drugs to tumor treatment.
The product is subject to the following: Abcam Restricted Use Statement
AdipoGen Terpyridine
Chemical. CAS 1148-79-4. Formula C15H11N3. MW 233.3. Synthetic. Reagent for the spectrophotometric det. of Ag and Ru. Tridentate ligand that binds metals at three meridional sites giving two adjacent 5-membered MN2C2 chelate rings. It forms complexes with most transition metal ions. It is also a potent inducer of nitrate and nitric oxide NO synthase iNOS protein and mRNA production in the cultured murine macrophage RAW 264.7 cell line.
Abcam PD0332991, Cdk4/Cdk6 inhibitor, 5MG
MW 447.5 Da, Purity >98%. Potent, highly specific inhibitor of Cdk4 (IC₅₀ = 11 nM) and Cdk6 (IC₅₀ = 16 nM). Displays selectivity for Cdk4/6 over a panel of 36 additional protein kinases (IC₅₀ values are > 10 μM). Induces G₁ cell cycle arrest and senescence in retinoblastoma protein (Rb)-proficient cell lines. Blocks growth of intracranial glioblastoma multiforme xenografts in mice. Blood-brain barrier permeable.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Sonidegib (NVP-LDE225, Erismodegib), smoothened (Smo) antagonist, 10MG
MW 485.5 Da. Potent and selective Smoothened antagonist. Blocks Hedgehog signaling pathway activity (IC₅₀ = 1.3 nM (mouse) and 2.5 nM (human) in cell-free assays. Anti-tumor activity in mouse medulloblastoma allograft model.
The product is subject to the following: Abcam Restricted Use Statement
Abcam LY2874455, FGF/FGFR inhibitor, 5MG
MW 444.3 Da, Purity >98%. Potent FGF/FGFR inhibitor. Inhibits in vitro autophosphorylation of FGFR-1, FGFR-2, FGFR-3, and FGFR-4 with similar inhibition potency for all four FGFRs (IC₅₀ < 6.4 nM). Exhibits a 6- to 9-fold in vitro and in vivo selectivity on inhibition of FGF- over VEGF-mediated target signaling in mice.
The product is subject to the following: Abcam Restricted Use Statement
Abcam GLPG-1690, 5MG
MW 588.7 Da, Purity >=98%. Selective autotaxin inhibitor with potential application in idiopathic pulmonary disease (IPF).
The product is subject to the following: Abcam Restricted Use Statement